Nanolipoprotein particle (NLP) vaccine confers protection against Yersinia pestis aerosol challenge in a BALB/c mouse model

IntroductionYersinia pestis is the etiological agent of plague, a disease that remains a concern as demonstrated by recent outbreaks in Madagascar. Infection with Y. pestis results in a rapidly progressing illness that can only be successfully treated with antibiotics given shortly after symptom ons...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Sergei S. Biryukov, Amy Rasley, Michael L. Davies, Christopher P. Klimko, Jennifer L. Dankmeyer, Melissa Hunter, Nathaniel O. Rill, Jennifer L. Shoe, Jeremy Miller, Yuli Talyansky, Barbara Sullinger, Matheo Herrera, Daniel Huang, Leslie Bautista, Lucy Pepe, Sandra K. G. Peters, Christian J. Xander, Elsie E. Martinez, Ronald G. Toothman, Kevin D. Mlynek, Joel A. Bozue, Ju Qiu, Nicholas O. Fischer, Christopher K. Cote
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2025-06-01
Цуврал:	Frontiers in Immunology
Нөхцлүүд:	plague Yersinia pestis vaccine nanolipoprotein particle mice pneumonic
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1603710/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!